Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Rank Gene Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 1 to 50 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
509\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8630.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7551.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14278\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
508\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8636.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7556.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14293\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
514\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8532.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7477\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1411\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
513\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8543.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7485.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14143\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 4 (ec 3.1.4.11) (phosphoinositide phospholipase c) (plc-beta-4) (phospholipase c-beta-4). [source:swissprot;acc:q15147]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3126\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
10 kda heat shock protein, mitochondrial (hsp10) (10 kda chaperonin) (cpn10). [source:swissprot;acc:q04984]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1136\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
10-formyltetrahydrofolate dehydrogenase (ec 1.5.1.6) (10-fthfdh). [source:swissprot;acc:o75891]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2922\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
14-3-3 protein beta/alpha (protein kinase c inhibitor protein-1) (kcip-1) (protein 1054). [source:swissprot;acc:p31946]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1411\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6262.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5812.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07743\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
14-3-3 protein epsilon (mitochondrial import stimulation factor l subunit) (protein kinase c inhibitor protein-1) (kcip-1) (14-3-3e). [source:swissprot;acc:p42655]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3088\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
14-3-3 protein zeta/delta (protein kinase c inhibitor protein-1) (kcip-1) (factor activating exoenzyme s) (fas). [source:swissprot;acc:p29312]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1415\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6265.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5815.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0774\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
14.5 kda translational inhibitor protein (p14.5) (uk114 antigen homolog). [source:swissprot;acc:p52758]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1600\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6788.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6336.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07145\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
15 kda selenoprotein precursor. [source:swissprot;acc:o60613]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1043\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6933.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6344.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09283\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
15-hydroxyprostaglandin dehydrogenase [nad(+)] (ec 1.1.1.141) (pgdh). [source:swissprot;acc:p15428]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2855\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
17 beta-hydroxysteroid dehydrogenase. [source:sptrembl;acc:q13034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2521\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6113.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5964.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02511\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2-hydroxyphytanoyl-coa lyase (ec 4.1.-.-) (2-hpcl) (hspc279). [source:swissprot;acc:q9uj83]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1393\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6192.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5743.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07824\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2-oxoglutarate dehydrogenase e1 component, mitochondrial precursor (ec 1.2.4.2) (alpha-ketoglutarate dehydrogenase). [source:swissprot;acc:q02218]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2506\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6362.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6200.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0261\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2-oxoisovalerate dehydrogenase alpha subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component alpha chain) (bckdh e1-alpha). [source:swissprot;acc:p12694]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2451\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6957.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6737.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component beta chain) (bckdh e1-beta). [source:swissprot;acc:p21953]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2288\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
20 kda nuclear cap binding protein (ncbp 20 kda subunit) (cbp20) (ncbp interacting protein 1) (nip1). [source:swissprot;acc:p52298]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
107\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5843.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4266.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.36977\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3079\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 4 (p26s4). [source:swissprot;acc:q03527]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1521\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6376.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5938.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07379\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 6a (tat-binding protein 1) (tbp-1) (proteasome subunit p50). [source:swissprot;acc:p17980]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1527\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6362.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5926.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07349\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 6b (mip224) (mb67 interacting protein) (tat-binding protein-7) (tbp-7). [source:swissprot;acc:p43686]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1567\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6242.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5822.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07226\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 7 (mss1 protein). [source:swissprot;acc:p35998]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1539\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6207.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07322\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 8 (proteasome subunit p45) (thyroid hormone receptor interacting protein 1) (trip1) (msug1 protein) (tat-binding protein homolog 10) (tbp10) (p45/sug). [source:swissprot;acc:p47210]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2651\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9234.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9150.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00914\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit s10b (proteasome subunit p42) (p44) (conserved atpase domain protein 44) (cadp44). [source:swissprot;acc:q92524]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1577\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6349.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5923.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07181\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 1 (26s proteasome regulatory subunit s1) (26s proteasome subunit p112). [source:swissprot;acc:q99460]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1883\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6195.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5826\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06342\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1609\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6242.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5826.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07134\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 11 (26s proteasome regulatory subunit s9) (26s proteasome regulatory subunit p44.5). [source:swissprot;acc:o00231]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1592\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6271.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5853.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07153\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1579\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6261.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5842.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 13 (26s proteasome regulatory subunit s11) (26s proteasome regulatory subunit p40.5). [source:swissprot;acc:q9unm6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1585\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6278.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5858.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07166\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1241\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6980.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6436.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08451\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 3 (26s proteasome regulatory subunit s3) (proteasome subunit p58). [source:swissprot;acc:o43242]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1546\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6244.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5819.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07303\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 4 (26s proteasome regulatory subunit s5a) (rpn10) (multiubiquitin chain binding protein) (antisecretory factor-1) (af) (asf). [source:swissprot;acc:p55036]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1979\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5800.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5475.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05939\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 6 (26s proteasome regulatory subunit s10) (p42a) (proteasome regulatory particle subunit p44s10). [source:swissprot;acc:q15008]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1472\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6435.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5984.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 7 (26s proteasome regulatory subunit s12) (proteasome subunit p40) (mov34 protein homolog). [source:swissprot;acc:p51665]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1571\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6273.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5851.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07208\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 8 (26s proteasome regulatory subunit s14) (p31). [source:swissprot;acc:p48556]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1536\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6350.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5916.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07344\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 9 (26s proteasome regulatory subunit p27). [source:swissprot;acc:o00233]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1517\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5996.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome-associated pad1 homolog. [source:refseq;acc:nm\_005805]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1643\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6186.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5782.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06977\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2720\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s12, mitochondrial precursor (mpr-s12) (mt- rps12). [source:swissprot;acc:o15235]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2153\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3381.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3560.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05302\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s16, mitochondrial precursor (mrp-s16) (cgi- 132). [source:swissprot;acc:q9y3d3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1955\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5510.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5195.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0607\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
115\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s18a, mitochondrial precursor (mrp-s18-a) (mrps18a) (mrp-s18-3). [source:swissprot;acc:q9nvs2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
835\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6218.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5623.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10592\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s26, mitochondrial precursor (mrp-s26) (mrp- s13). [source:swissprot;acc:q9byn8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2071\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6797.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6437.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05592\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s9, mitochondrial precursor (mrp-s9). [source:swissprot;acc:p82933]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2530\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3788.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3880.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02431\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3 beta-hydroxy-delta 5-c27-steroid oxidoreductase. [source:refseq;acc:nm\_025193]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3147\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
3 beta-hydroxysteroid dehydrogenase (fragments). [source:sptrembl;acc:q9udk8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2756\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type i (3beta-hsd i) (trophoblast antigen fdo161g) [includes: 3-beta-hydroxy- delta(5)-steroid dehydrogenase (ec 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (progesterone reductase); steroid delta- isomerase (ec 5.3.3.1) (delta-5-3-ketosteroid isomerase)]. [source:swissprot;acc:p14060]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2802\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/